APLS
Apellis Pharmaceuticals Inc

3,682
Mkt Cap
$2.68B
Volume
1.87M
52W High
$30.48
52W Low
$16.10
PE Ratio
169.72
APLS Fundamentals
Price
$20.96
Prev Close
$21.64
Open
$21.30
50D MA
$23.15
Beta
1.02
Avg. Volume
4.02M
EPS (Annual)
$0.1724
P/B
7.17
Rev/Employee
$1.36M
$3,268.56
Loading...
Loading...

About

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
739

Frequently Asked Questions

What is Market Cap of Apellis Pharmaceuticals Inc?
What is the 52-week high for Apellis Pharmaceuticals Inc?
What is the 52-week low for Apellis Pharmaceuticals Inc?
What is Apellis Pharmaceuticals Inc stock price today?
What was Apellis Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Apellis Pharmaceuticals Inc?
What is the Price-to-Book ratio of Apellis Pharmaceuticals Inc?
What is the 50-day moving average of Apellis Pharmaceuticals Inc?
How many employees does Apellis Pharmaceuticals Inc have?

Latest APLS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.